Current Drug Targets - CNS & Neurological Disorders
Title: Preface [Hot Topic: Subtypes of the 5HT Receptor (Guest Editors: Mark D. Tricklebank and Derek N. Middlemiss)]
Volume: 3 Issue: 1
Author(s): Mark D. Tricklebank and Derek N. Middlemiss
Affiliation:
Export Options
About this article
Cite this article as:
Tricklebank D. Mark and Middlemiss N. Derek, Preface [Hot Topic: Subtypes of the 5HT Receptor (Guest Editors: Mark D. Tricklebank and Derek N. Middlemiss)], Current Drug Targets - CNS & Neurological Disorders 2004; 3 (1) . https://dx.doi.org/10.2174/1568007043482589
DOI https://dx.doi.org/10.2174/1568007043482589 |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
Related Articles
-
May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?
Cardiovascular & Hematological Disorders-Drug Targets Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules
Current Topics in Medicinal Chemistry Cognitive Event-Related Potentials: Useful Clinical Information in Alzheimers Disease
Current Alzheimer Research Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design Skeletal Effects of Central Nervous System Active Drugs: Anxiolytics, Sedatives, Antidepressants, Lithium and Neuroleptics
Current Drug Safety UCLA’s Molecular Screening Shared Resource: Enhancing Small Molecule Discovery with Functional Genomics and New Technology
Combinatorial Chemistry & High Throughput Screening Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
Current Pharmaceutical Design BACE Inhibitors as Potential Therapeutics for Alzheimers disease
Recent Patents on CNS Drug Discovery (Discontinued) Onconeural Versus Paraneoplastic Antigens?
Current Medicinal Chemistry The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review
CNS & Neurological Disorders - Drug Targets Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease
Current Alzheimer Research Editorial [Hot topic: In Silico Approaches in G Protein-Coupled Receptors (GPCRs) Drug Discovery: Quo Vadis? (Executive Editor: Stefano Moro)]
Current Pharmaceutical Design Creating Chemical Diversity to Target Protein Kinases
Combinatorial Chemistry & High Throughput Screening Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease
Current Psychopharmacology Antimicrobial Sensitivity Pattern of Bacterial Pathogens in Urinary Tract Infections in South Delhi, India
Reviews on Recent Clinical Trials Effect of Nigella Sativa and Allium Sativum Coadminstered with Simvastatin in Dyslipidemia Patients: A Prospective, Randomized, Double-Blind Trial
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry SCYPPred: A Web-Based Predictor of SNPs for Human Cytochrome P450
Protein & Peptide Letters Nitric Oxide: News from Stem Cells to Platelets
Current Medicinal Chemistry